Recursion Pharmaceuticals is expanding its clinical pipeline across oncology and rare diseases, with REC-4881 and multiple programs offering potential growth catalysts.
Argument about recursive self-improvement is loud, and very little of it is about evidence. It is about process. Everyone in ...
Cellunova Productions will present a workshop production of the AANHPI science-fiction play, written by Brandon Zang and ...
Anthropic and OpenAI's calls to 'pace the frontier' hinge on claims of imminent recursive self-improvement (RSI), yet current ...
Eunji Lim will lead the cast of THE RECURSION OF A MOTH, a new play by Brandon Zang directed by Seonjae Kim, at Teatro ...
Explore recursive self-improvement, agentic AI risks and the AI singularity debate, including OpenAI security incidents and ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
OpenAI CEO Sam Altman warns AI development must be paced by stronger safeguards as industry leaders grapple with the technology’s accelerating capabilities and risks.
Top executives from three of the country's leading AI companies issued exceptional calls for collaboration on a path forward that could "pace the frontier" of AI development.
Some Anthropic engineers think AI might end us. Why race ahead? - Opinion, Their Views | Hawaii Tribune-Herald ...
A philosophical dialogue between Martin LeFevre and an artificial intelligence examined the parameters of the AI alignment ...
Artificial intelligence (AI) is poised to reshape pharmaceutical research by addressing some of the industry's most persistent challenges: lengthy timelines, high development costs and substantial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results